Skip to main content
EC

Every Cure

Every Cure uses AI-driven analysis of existing drug and disease data to identify repurposing opportunities. It advances the most promising candidates through preclinical and clinical development to address unmet medical needs. The organization aims to expand patient access to affordable, effective therapies by leveraging already approved medications.

Los Angeles, United StatesFounded 2022397K+ followers
Updated 20 months ago

Funding

$60M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

TA
Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Millions of individuals globally suffer from diseases lacking FDA-approved treatments, while many existing drugs remain underutilized. Traditional drug discovery is a lengthy and expensive process, limiting the potential to rapidly address unmet medical needs.

Solution

Every Cure is developing an open-source, AI-driven platform, called MATRIX, to identify existing drugs that can be repurposed to treat diseases without approved treatments. The platform analyzes a comprehensive dataset of drug and disease information to generate predictive efficacy scores for all FDA-approved drugs against all known diseases. By identifying promising drug-disease matches, Every Cure aims to accelerate the development of new treatments and improve patient outcomes. The platform also includes a portal for physicians, researchers, and patients to contribute repurposing ideas, fostering collaboration and knowledge sharing.

Target Audience

The primary audience includes researchers, clinicians, and healthcare organizations seeking to identify and develop new uses for existing drugs, as well as patients suffering from diseases with limited treatment options.

Features

  • AI-powered engine that generates predictive efficacy scores for existing drugs against a wide range of diseases
  • Open-source drug repurposing database accessible to researchers and clinicians
  • Web portal for submitting drug repurposing ideas and contributing data
  • Integration of proprietary and public data into a comprehensive dataset
  • Algorithms to identify and validate promising drug-disease matches
This profile is AI-generated and may contain inaccuracies.